Spots Global Cancer Trial Database for hepatic arterial infusion chemotherapy + atezolizumab and bevacizumab
Every month we try and update this database with for hepatic arterial infusion chemotherapy + atezolizumab and bevacizumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation | NCT05833126 | Recurrent Liver... | Hepatic arteria... | 18 Years - 75 Years | Third Affiliated Hospital, Sun Yat-Sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
